在囊性纤维化中Ceftobiprole:一个病例系列
Lisa Nwankwo1,2, Silke Schelenz3, Newara Ramadan4
1Pharmacy Department, Royal Brompton and Harefield Hospital, Guy's and St. Thomas' NHS Foundation Trust, London SW3 6NP, UK.
JAC-antimicrobial resistance
|May 20, 2025
概括
塞夫托比普罗尔在治疗囊性纤维化 (CF) 患者的细菌感染方面表现有前途,改善肺功能和减少炎症. 这种抗生素为CF患者提供了潜在的新选择,治疗选择有限.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 囊性纤维化 (CF) 涉及CF跨膜导电性调节器 (CFTR) 基因的突变,导致粘性粘液和对感染的敏感性增加.
- 感染性恶化是CF患者发病和死亡的主要原因,需要有效及及时的抗菌药物治疗.
- 塞夫托比普罗尔是第五代塞法洛斯波林,它对关键的CF病原体如金黄色葡萄球菌 (包括MRSA) 和Pseudomonas aeruginosa表现出活性.
研究的目的:
- 评估 ceftobiprole 在治疗囊性纤维化患者感染性恶化症的临床效用.
- 评估 ceftobiprole 对肺功能和 CF 患者炎症标志物的影响.
主要方法:
- 一组10名囊性纤维化患者 (年龄24-63岁) 患有感染性恶化,接受了 ceftobiprole 治疗.
- 治疗决策由多学科团队做出,通常涉及同时服用其他抗生素.
- 监测患者的结果,包括肺功能,炎症标志物和耐受性.
主要成果:
- 所有患者的唾液培养呈阳性S. aureus (9人患有MRSA),7人同时患有P. aeruginosa感染.
- 对大多数患者来说,塞夫托双治疗与肺功能改善和全身炎症标志物减少有关.
- 抗生素的耐受性一般很好,只有四名患者出现不良反应.
结论:
- 塞夫托比普罗尔代表了一种可行的治疗选择,用于性纤维化患者的易感感染,这些患者面临着有限的治疗选择.
- 它的广泛活动可能有助于减少在CF管理中对多药的需求.
- 需要进一步的临床研究,以充分确定 ceftobiprole 在CF护理中的作用.
相关概念视频
Cystic Fibrosis: Pathogenesis
174
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
174
Cystic Fibrosis: Management
136
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
136
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Drugs for Treatment of Constipation-Predominant IBS
124
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
124
Pulmonary Tuberculosis V
159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
Pulmonary Function Tests
285
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
285


